Wellsense
Wellsense is a private medical device company that develops the FDA-registered Wellsense Vū, a real-time continuous bedside pressure monitoring and visualization system designed to help hospitals prevent hospital-acquired pressure injuries in critical care, burn, and long-term care settings.
- Company typePrivate
- Founded2009
- HeadquartersBirmingham, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Wellsense does
Wellsense, Inc. is a private medical device company founded in 2009 and headquartered in Birmingham, Alabama. The company develops and manufactures the Wellsense Vū, an FDA-registered Class I real-time continuous bedside pressure monitoring and visualization system designed to detect and display pressure distribution on patient surfaces. The technology addresses the clinical problem of hospital-acquired pressure injuries (HAPIs) by giving nurses visual feedback on patient pressure states through a structured SEE-OFFLOAD-CONFIRM workflow: assess present pressure, review past pressure patterns via 2-hour video feedback compression, and ensure future pressure management with optional EMR integration and voice input. The product is differentiated by what the company describes as the only pressure monitoring solution to qualify for meta-analysis after review of 1,866 published articles over 11 years, with an 88% reduction in pressure injury risk validated by a Johns Hopkins-led meta-analysis and outcomes published in peer-reviewed journals including Advances in Skin & Wound Care and BMJ Quality & Safety.
Wellsense operates an enterprise field sales motion targeting hospital clinical leadership, nursing management, and administrators across critical care units, burn units, long-term care facilities, and Veterans Health Administration sites. Named deployments include Johns Hopkins Burn Center, Henry Ford Hospital, University of Kansas Hospital Burnett Burn Center, Methodist Dallas Medical Center, Swedish Medical Center, Floyd Medical Center, Carl T. Hayden VA Medical Center, SSM DePaul Health Center, Villa Maria Care Center, and two UK NHS acute orthopedic trauma wards. The company is HIPAA and SOC2 compliant, supports an optional EMR integration with voice input, and markets primarily in the United States with a limited UK footprint.
The business model is centered on hardware sales of the Wellsense Vū device on a per-bed or per-unit basis, supplemented by a CapEx-free strategic deployment option that targets highest-risk patients within hospitals. Contracts are structured as multi-year agreements. Since 2011 the company has filed nine SEC Form D exempt securities offerings totaling approximately $21.9 million, with the most recent filing in March 2024 covering up to $6 million ($5.62 million sold). Leadership includes CEO Ron Ferber, founder Itai Arad, COO Mordechai Lev, and director Ran Poliakine. The company employs 11–50 people and remains in growth-investment mode rather than at scale.
Wellsense firmographics
Firmographics- Name
- Wellsense
- Legal name
- Wellsense, Inc.
- Website
- https://wellsensevu.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Wellsense is a private medical device company that develops the FDA-registered Wellsense Vū, a real-time continuous bedside pressure monitoring and visualization system designed to help hospitals prevent hospital-acquired pressure injuries in critical care, burn, and long-term care settings.
- Ownership category
- akta.pro rank
Wellsense industry classification
Industry- Product category
- Patient Monitoring Medical Devices
- akta.pro primary industry
- Infusion Pumps (Ambulatory/Stationary) (HLAHAIAF)
- akta.pro secondary industries
- Peritoneal Dialysis (PD) Systems & Supplies (HLAHAKAB), Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL)
Keywords
Where Wellsense is headquartered
LocationHeadquarters
- HQ city
- Birmingham
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Wellsense business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Medical Device Sales: Sale of Wellsense VŪ real-time pressure monitoring system as a Class I medical device to healthcare facilities. The device is deployed on a per-bed or per-unit basis targeting high-risk patients. CapEx-free deployment model available where the company provides the technology for strategic deployment in high-risk areas.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | CapEx-Free Strategic Deployment |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Wellsense product offering
Product offeringCore offering
Wellsense develops and manufactures Wellsense Vū, a Class I FDA-registered real-time pressure monitoring medical device designed for hospital critical care settings. The system continuously measures interface pressure between patients and support surfaces (such as ICU beds) to help clinicians prevent pressure injuries (bedsores). The company targets acute care hospitals and intensive care units where immobilized patients are at high risk of pressure-related tissue damage.
Product overview
Wellsense offers a single unified product: Wellsense VŪ, a real-time pressure monitoring and visually guided pressure offloading system. The product is a Class I medical device that gives nurses real-time visibility into patient pressure, enabling them to see pressure levels, offload with precision, and confirm that interventions were effective. The system includes features for assessing present pressure, reviewing past pressure through 2-hour video feedback, and ensuring future pressure management through EMR integration with voice input options.
Differentiator
Problem solved
Functional benefit
Products and services
- Wellsense Vū Pressure Monitoring System
Quantifiable outcome
- 88% reduction in pressure injury risk (Johns Hopkins-led meta-analysis)
- +4 more outcomes
Companies that use Wellsense
Customer profileNamed customers10 records
Segments4 records
Ideal customer profiles1 record
Wellsense technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature4 records
Wellsense partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights5 records
Wellsense competitors and assessment
Company assessmentDirect peers
- Bruin Biometrics: Bruin Biometrics manufactures the SEM Scanner, a hand-held sub-epidermal moisture scanner for early pressure injury detection. It is the most direct competitor to Wellsense Vū, targeting the same hospital PI-prevention use case with a point-in-time diagnostic rather than continuous monitoring.
- Leaf Healthcare: Leaf Healthcare offers a wireless patient turning and mobility sensor system designed to prevent hospital-acquired pressure injuries through continuous monitoring of patient repositioning. Highly comparable to Wellsense on technology approach (continuous bedside monitoring) and target buyer (hospital nursing leadership).
- EarlySense: EarlySense provides contact-free continuous patient monitoring (heart rate, respiratory rate, motion) for hospital beds, addressing patient safety events including falls and deterioration. Comparable as a continuous bedside sensor platform sold into the same hospital enterprise channel.
Broad incumbents
- Mölnlycke Health Care: Mölnlycke is a global wound care leader with Mepilex Border and other PI-prevention dressings. It addresses the same HAPI problem with a different mechanism (advanced dressings vs. continuous monitoring) and competes for the same hospital wound-care budget.
- Smith+Nephew: Smith+Nephew's Advanced Wound Management portfolio (ALLEVYN, PICO) competes for hospital PI-prevention spend. A broad incumbent with deep hospital sales coverage; not a continuous-monitoring peer but competes for the same clinical and budgetary mindshare.
- ConvaTec: ConvaTec supplies wound and skin care products (including foam dressings) used in PI prevention and treatment. A broad incumbent serving the same hospital wound-care stakeholders that buy PI-prevention solutions.
- 3M Health Care: 3M's Health Care division includes wound management and skin integrity products used for pressure injury prevention. A massive incumbent with strong hospital procurement relationships; overlaps with Wellsense at the budget-allocation level.
- Coloplast: Coloplast's Wound Care business offers dressings and skin care products used in pressure injury prevention and treatment. A broad incumbent serving similar clinical customers across U.S. and European hospital systems.
- Baxter International (Hillrom): Baxter acquired Hillrom, whose Centrella and Progressa smart hospital beds integrate surface pressure sensing and turn-assist features. Competes with Wellsense at the hospital-bed level for capital budget and increasingly for connected-bed data.
- Stryker: Stryker's Medical division includes smart hospital beds (ProCuity, iBed) with integrated pressure redistribution and patient monitoring. A broad incumbent whose connected-bed strategy overlaps with Wellsense's bedside pressure monitoring thesis.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Wellsense social profiles
Digital presenceWellsense compliance and trust
Trust signalCompliance3 records
Wellsense financial estimates
Financial estimateRevenue estimate
Valuation estimate
Wellsense leadership team
Management profileNumber of profiles
Profiles4 records
Wellsense funding detail
Funding detailFunding overview
Funding rounds9 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Wellsense M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Wellsense
What does Wellsense do?
Wellsense develops and manufactures Wellsense Vū, a Class I FDA-registered real-time pressure monitoring medical device designed for hospital critical care settings. The system continuously measures interface pressure between patients and support surfaces (such as ICU beds) to help clinicians prevent pressure injuries (bedsores). The company targets acute care hospitals and intensive care units where immobilized patients are at high risk of pressure-related tissue damage.
Is Wellsense a public or private company?
Wellsense is a private company. It is classified as venture growth investor backed and is currently operating.
When was Wellsense founded?
Wellsense was founded in 2009. It employs 11 to 50 people.
Where is Wellsense based?
Wellsense is headquartered in Birmingham, United States, in the North America region.
How does Wellsense make money?
One revenue line is on record: medical Device Sales.
Who are Wellsense's main competitors?
Direct peers on record are Bruin Biometrics, Leaf Healthcare and EarlySense. Broad incumbents are Mölnlycke Health Care, Smith+Nephew, ConvaTec, 3M Health Care, Coloplast, Baxter International (Hillrom) and Stryker.
Does Wellsense have an API?
No public API is recorded for Wellsense.
What industry is Wellsense in?
Wellsense's product category is Patient Monitoring Medical Devices. Its primary akta.pro industry code is HLAHAIAF, Infusion Pumps (Ambulatory/Stationary), with a secondary code of HLAHAKAB, Peritoneal Dialysis (PD) Systems & Supplies.